AstraZeneca lifts FTSE 100 to record high

AstraZeneca lifts FTSE 100 to record high


London’s benchmark FTSE 100 stock index opened at a record high on Wednesday led by AstraZeneca, after the drugmaker initiated a worldwide withdrawal of its Covid-19 vaccine, while investors awaited the Bank of England’s interest rate verdict.

By 07:07 GMT, the blue-chip FTSE 100 edged up 0.4 per cent at 8,345.31 to climb another all-time peak.

The mid-cap FTSE 250 gained 0.1 per cent, set to rise for a third straight session. Both indexes have recorded consistent gains on a weaker pound that slipped 0.2 per cent against the dollar.

AstraZeneca advanced 1.1 per cent after the drugmaker said it initiated a worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.

All eyes will be on the BOE’s interest rate decision on Thursday (May 9), where it is widely expected to keep rates unchanged. However, dovish bets have risen recently, with markets pricing in a first rate cut in August.

Shell inched 0.2 per cent higher, after the energy giant agreed to sell its refinery and petrochemical assets in Singapore to a joint venture between Indonesia’s PT Chandra Asri Pacific and Glencore

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

J D Wetherspoon was up 3.6 per cent, as the pub group forecast profit to be towards the upper end of market expectations, after it posted higher sales in the third quarter. REUTERS

Posted in

Riah Marton

I'm Riah Marton, a dynamic journalist for Forbes40under40. I specialize in profiling emerging leaders and innovators, bringing their stories to life with compelling storytelling and keen analysis. I am dedicated to spotlighting tomorrow's influential figures.

Leave a Comment